Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

Erstveröffentlichung
2020
Authors
Davids, Matthew S.
Kuss, Bryone J.
Hillmen, Peter
Montillo, Marco
Moreno, Carol
et al.
Wissenschaftlicher Artikel


Published in
Clinical Cancer Research ; 26 (2020), 9. - S. 2096-2103. - ISSN 1078-0432. - eISSN 1557-3265
Link to publication
https://dx.doi.org/10.1158/1078-0432.CCR-19-3061
Institutions
UKU. Klinik für Innere Medizin III
Subject headings
[Free subject headings]: CHRONIC LYMPHOCYTIC-LEUKEMIA | OPEN-LABEL | VENETOCLAX | INHIBITOR | IBRUTINIB
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record